A Full Face Study to Evaluate the Efficacy of Dermapen 4™ Microneedling Device in Addition with MG-CLR Serum for Acne Treatment Over 12 Weeks.
PHASE2/PHASE3Not yet recruitingINTERVENTIONAL
Enrollment
10
Participants
Timeline
Start Date
October 31, 2024
Primary Completion Date
March 31, 2025
Study Completion Date
March 31, 2025
Conditions
Acne
Interventions
COMBINATION_PRODUCT
Dermapen 4™
Dermapen 4™ conjunction with MG-CLR
Trial Locations (1)
35209
Skin Wellness Dermatology, Birmingham
All Listed Sponsors
lead
Equipmed USA LLC
INDUSTRY
NCT06602284 - A Full Face Study to Evaluate the Efficacy of Dermapen 4™ Microneedling Device in Addition with MG-CLR Serum for Acne Treatment Over 12 Weeks. | Biotech Hunter | Biotech Hunter